Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Oilfield continues growing very nicely, and that provides a positive price mix. So we are very pleased with how we are returning the Surfactant business, which is at the end, 70% of the company ...

also known as SCL-70 (positive in 30% of SSc patients), is specific to SSc. Two thirds of patients with this antibody have diffuse SSc and pulmonary interstitial fibrosis as well as reduced survival.

For this purpose, a doctor may order anti-dsDNA, anti-Sm, Sjögren's antigens (SSA, SSB), Scl-70 antibodies, anti-centromere, anti-histone, and anti-RNP. The ANA blood test can seem complicated. The ...

1 2 Myositis autoantibodies can be detected in approximately 60%–70% of children and adults with IIM ... of the 8.1 AH were observed for patients with anti-Jo-1, anti-PM/Scl and anti-cN1A. Anti-HMGCR ...

Primary outcomes Prevalence of severe (subclinical level) and very severe symptoms (clinical level) were computed using the Dutch norm tables (80th percentile and 95th percentile, respectively) of the ...

Pre-Tax Cost Savings for 2024: $48 million. Stepan Co (NYSE:SCL) reported a 4% growth in full-year adjusted EBITDA despite several one-time events negatively impacting earnings. The surfactant and ...

Stepan (NYSE:SCL – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday following a weaker than expected earnings announcement. The stock traded as low as $59.55 and last ...

The Wild Robot and The Brutalist took the Original Score film prizes, and Atticus Ross scored a pair of trophies at the sixth annual SCL Awards, which were handed out Wednesday night at the ...